Displaying drugs 501 - 525 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Remimazolam | 439.313 C21H19BrN4O2 |  | An ultra short-acting benzodiazepine used for the induction and maintenence of procedural sedation during short procedures. | Benzodiazepines and benzodiazepine derivatives |
| Bromperidol | 420.322 C21H23BrFNO2 |  | A first-generation butyrophenone antipsychotic used in the treatment of schizophrenia and other psychotic manifestations. | Butyrophenone Derivatives |
| Relebactam | 348.37 C12H20N4O6S |  | A beta-lactamase inhibitor used to prevent hydrolysis of beta-lactam antibiotics, leading to increased effectiveness. | beta-Lactamase Inhibitors |
| Siponimod | 516.605 C29H35F3N2O3 |  | A medication used to treat relapsing multiple sclerosis. | Selective Immunosuppressants / Sphingosine-1-phosphate (S1P) receptor modulators |
| Betrixaban | 451.91 C23H22ClN5O3 |  | A Factor Xa inhibitor used for prophylaxis of venous thromboembolism in hospitalized patients. | Direct factor Xa inhibitors |
| Diaminopropanol tetraacetic acid | 322.27 C11H18N2O9 |  | Diaminohydroxypropanetetraacetic acid has been investigated for the treatment of Vascular Disease, Coronary Disease, Myocardial Ischemia, Coronary Restenosis, and Coronary Artery Disease, among others. | Not Annotated |
| Temocillin | 414.45 C16H18N2O7S2 |  | Temocillin has been investigated in Infection, Liver Dysfunction, and Urinary Tract Infection. | Penicillins With Extended Spectrum |
| Rucaparib | 323.371 C19H18FN3O |  | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat recurrent ovarian and prostate cancers in previously treated adults. | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| Eravacycline | 558.563 C27H31FN4O8 |  | A tetracycline antibiotic used to treat complicated intra-abdominal infections. | Tetracyclines |
| Cantharidin | 196.202 C10H12O4 |  | A natured product indicated to treat molluscum contagiosum | Benzofurans / Enzyme Inhibitors / Irritants |
| Dopexamine | 356.5017 C22H32N2O2 |  | Dopexamine has been used in trials studying the diagnostic and treatment of Free Flap, Oral Cancer, Hypotension, Septic Shock, and Head and Neck Cancer. | Adrenergic and Dopaminergic Agents |
| Doravirine | 425.749 C17H11ClF3N5O3 |  | A non-nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals to treat HIV-1 infections. | Non-Nucleoside Reverse Transcriptase Inhibitors |
| P-nitrobiphenyl | 199.209 C12H9NO2 |  | Pnb has been used in trials studying the treatment of Pelvic Organ Prolapse. | Not Annotated |
| Nefopam | 253.345 C17H19NO |  | A non-opioid analgesic used for moderate to severe pain, especially post-surgical pain. | Analgesics |
| Propiverine | 367.4813 C23H29NO3 |  | An antimuscarinic agent used to treat urinary incontinence or increased urinary frequency or urgency. | Drugs for Urinary Frequency and Incontinence |
| Polihexanide | Not Annotated |  | Polihexanide has been used in trials studying the treatment, prevention, and supportive care of Caries, Neoplasm, Skin Diseases, Nail Diseases, and Dental Plaque, among others. | Biguanides and Amidines |
| Brigatinib | 584.1 C29H39ClN7O2P |  | An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors |
| Fexinidazole | 279.31 C12H13N3O3S |  | An orally bioavailable 2-substituted 5-nitroimidazole used to treat early- and late-stage human African trypanosomiasis caused by Trypanosoma brucei gambiense. | Nitroimidazole Derivatives |
| Vadadustat | 306.7 C14H11ClN2O4 |  | An oral hypoxia-inducible factor prolyl-hydroxylase inhibitor used to treat symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis. | Amino Acids / Amino Acids, Peptides, and Proteins / Antianemic Preparations / BCRP/ABCG2 Inhibitors / Blood and Blood Forming Organs / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (weak) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Erythropoiesis-Stimulating Agents / Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors / OAT3/SLC22A8 Inhibitors / OAT3/SLC22A8 Substrates / Pyridines / UGT1A1 Inducers / UGT1A1 Substrates / UGT1A9 Substrates / UGT2B7 substrates |
| Triclabendazole | 359.65 C14H9Cl3N2OS |  | An anthelmintic drug used to treat fascioliasis. | Antihelminthic / Antiplatyhelmintic Agents / Benzimidazoles |
| Edaravone | 174.203 C10H10N2O |  | A free radical scavenger used to delay the progression of ALS. | Free Radical Scavengers / Neuroprotective Agents |
| Bexagliflozin | 464.94 C24H29ClO7 |  | A sodium-glucose co-transporter 2 inhibitor used to improve glycemic control in patients with type 2 diabetes mellitus. | Blood Glucose Lowering Agents |
| Estetrol | 304.3808 C18H24O4 |  | An estrogen used in combination with drospirenone for oral contraception. | Estrogens |
| Capivasertib | 428.915 C21H25ClN6O2 |  | A serine/threonine kinase inhibitor used to treat hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer | Proto-Oncogene Proteins c-akt, antagonists & inhibitors |
| Iron isomaltoside 1000 | Not Annotated |  | Iron isomaltoside 1000 is under investigation in Iron Deficiency Anaemia. Iron isomaltoside 1000 has been investigated for the treatment and basic science of Anemia, Gastric Cancer, Esophageal Cancer, Chronic Kidney... | Hematinics |
Displaying drugs 501 - 525 of 2785 in total